UNSPSC 85632109: Revision of autologous tissue substitute in right breast, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of autologous tissue substitute in right breast, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0HWT37Z

UNSPSC 85632109 Revision of autologous tissue substitute in right breast, percutaneous approach is a Commodity code with no recent state and local procurement activity aligned to its scope. The six posted opportunities from September and August 2026 span occupational medical surveillance for ferry workers (Washington State Department of Transportation), independent disability medical evaluations for public safety pension boards (City of Phoenix Retirement Office), surgical benefit carve-out programs for city employees (City of Long Beach), emergency and specialty medical services for detained youth (Harris County Juvenile Probation Department), pharmacy benefit management (Collier County Board of County Commissioners), and temporary health professional staffing across ancillary clinical categories (County of Santa Clara Health System). None of these solicitations involve breast tissue revision, autologous tissue procedures, or related surgical reconstruction work; the code appears to have been applied to a health-benefits or administrative services record rather than a specific medical procedure procurement.

State and local governments do not appear to procure surgical procedures themselves under this code tier or related categories. Opportunities in the health-services space involve staffing, benefit administration, claims processing, and occupational health compliance—administrative and operational functions rather than tissue banking, surgical implants, or procedure-specific supplies. Bidders pursuing this code should verify that their target agencies actually solicit for tissue-based surgical materials or autologous substitute services before building pursuit strategy; the present dataset shows no market signal in this segment.